Pamicell Ranks High in Search... Stock Price Up 0.31%

Pharmicell is trading at 15,950 KRW as of 1:30 PM on the 19th, up 0.31% from the previous day. This represents a 21.43% decline compared to September 15. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net sellers of 33,051 shares. Over the past five days, individual investors have net sold 208,329 shares, while foreigners and institutions have net bought 242,948 shares and net sold 43,027 shares, respectively.

On October 16, Pharmicell became an issue in the market due to the announcement by WHO that remdesivir is 'ineffective,' which led to a decline.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.